A physiologically ingestible composition with microstructured water having a negative oxidation reduction potential of at least -40, and uses thereof are provided. The composition may further included dissolved oxygen, which may be present in an amount of 20 ppm to 150 ppm. The physiologically ingestible composition may be administered to reduce fatigue in a mammal.